MS Morgan Stanley

Bankers have told potential investors the Anthropic could target a valuation exceeding $2T (more than double its ~$965B private mark from the May Series H) & potentially raise more than $100B, which would make it the largest IPO on record & surpass SpaceX’s earlier 2026 debut. $MS is positioned for the lead-left role, w/ $GS as co-lead. JPMorgan & Citigroup are also in the top tier of the syndicate The newly detailed prospectus shows rapid top-line growth alongside heavy investment: • Revs: $4.59B, up +1,088% y/y from $386M • Op loss: $8.06B, widening from $2.98B in 2024. • GAAP net loss: $41.97B, vs $8.31B the prior year. That headline ~$42B net loss requires context- roughly $34B stemmed from an accounting charge tied largely to the rising value of financing instruments that could eventually convert into Anthropic shares, rather than cash spent running the business Anthropic spent $7.33B on compute & infrastructure in 2025—up +190% y/y & nearly 3x the prior year. That alone represented: • 58% of its $12.65B in total op expenses • Roughly 1.6x its entire annual revs Spending is expected to keep climbing. The prospectus outlines roughly $518B in cloud, compute & infrastructure obligations as the company continues building out its AI systems. Anthropic ended 2025 w/ $20.28B in total cash Its 2 largest direct customers each acct’d for 12% of revs, meaning just 2 customers represented 24% of total 2025 sales Anthropic warns that many of its largest customers are not locked into long-term contracts & could reduce or stop spending $AMZN & $GOOGL are also major strategic partners & investors in Anthropic, while supplying much of the cloud infrastructure needed to train & run Claude The IPO could come after the Nov US midterm elections & would give public-market investors one of their 1st pure-play ways to value a frontier AI lab The filing highlights risks around increasingly autonomous AI systems, including unexpected behavior, security concerns & potential misuse

$MS $GS After the recent stumbling in the ipo calendar thanks to Anthropic and OpenAi twirling, last week’s bond mkt follies and more endless Trump drivel on Iran crap, I came to the view that the financials are bottoming on bs… When the turnaround becomes apparent, the pile in will begin and likely be violent to the upside. I reloaded both names Friday. LONG 25K of MS AND 3k of GS. F the big banks and their massively underwater bond portfolios going back to Covid nonsense days and super low zero bond rates… they are hosed for years on those butch allocations. Imo, you just own the two best names, MS GS. The financials are trading at record lows….TIME TO WADE IN ON A BG SWING TRADE.

$MS is pulling back into a key weekly support trendline that has helped define the broader uptrend since 2025. Price is now testing the lower end of the rising channel, making this an important area to watch for a potential bullish reaction and continuation higher.

Sentiment track for companies reporting tomorrow morning. $MS occupies the Extremely Bullish zone alone. $ASML is exhibiting the steepest ascent moving from the Bearish zone to the top edge of the Bullish zone. $SOTK is the only name to have been in the Extremely Bullish zone yet had fallen hard into the Bearish zone. Other large financials $BLK and $BAC in the Bullish zone.

$MS $GS Have flip traded 7k (3 trades) of gs this week for just under $26K. Added 8k to the 25k ms swing rebought this week. Both report next week. Will reload 5k gs Monday if no nukes fired on Iran. Rip Rip!

$MS $GS do you think either of these has huge underwater bond and com'l real estate portfolios relative to capital like $BAC and $JPM? I know they don't... Just put on 25k of $MS and$3K of GS while the RSI is on the floor and everyone long is hanging off the back of the ship blowing lunch. Those short down here really ought to do some rememedial study of this important reading:

$MS $XLF Morgan Stanley (MS) - Daily Earnings Catalyst 10/14/26 - Which could potentially help rectify the current situation, but price is starting to lose a key area of market memory/polarity with bearish momentum readings - going back to mid January. 👀

$MS looks as if price digested ER at the end of a regular abc-correction. means it's ready for a fresh run, 25% below ATH

$MS This should be in $200 s today. No reason for it to go down on an earnings beat with other loser banks.

$MS Key Metrics vs. Consensus: • EPS: $3.03 (vs. $2.91 expected) 🚀 • Revenue: $20.34B (vs. $19.95B expected) 📈 (+12% YoY) • Net Income: $4.91B | ROTCE: 22.6% Segment Highlights: • Institutional Securities: $10.03B (vs. $9.21B exp) • Equities: $5.80B (Smashed $4.90B exp by ~$1B!) 🤯 • IB Revenue: $2.16B (In line with estimates) • Wealth Management: $9.1B revenue (30.4% margin). Added $232B net new assets. • Investment Management: $1.46B revenue ($2.05T total AUM). Capital Returns: $1.5B in stock buybacks; $1.15/share dividend. Takeaway: Blowout quarter driven by a massive $1B beat in equities trading and relentless wealth inflows.

$MS bought some more on the pullback. If earnings are good and we climb tomorrow then I’ll have made a good choice. If it tanks I will double my position as I have money coming soon

Morgan Stanley just committed $684M to build a new services hub in Dallas. That's real conviction in U.S. growth, not a press release for show. $MS quietly playing the long game while everyone watches the headlines elsewhere. 👀

$MS (Morgan Stanley, the investment bank and wealth manager) earned $3.03 a diluted share in Q3 2026, down 12% from Q2's $3.46, as net revenues fell 5% to $20.3B and trading revenue dropped 17% from Q2. That is $4.9B of quarterly profit for a firm valued near $298B at the Oct 12 close of $190.02. Other side: vs Q3 2025, revenue rose 12% and EPS rose from $2.80; Wealth Management posted record revenue of $9.1B and $232B of net new assets, just over half tied to IPOs. Next: $1.15 quarterly dividend, record Oct 30, paid Nov 13.

$MS | Q3 2026 Post-Earnings Research Update Rating: BUY 12-Month Price Target: $219.00 (+17.7% upside vs. $186.00) Horizon: 12 Months Core Thesis: Morgan Stanley's Q3 results validate its hybrid compounder model, as record Wealth Management revenue ($9.1B at a 30.4% pre-tax margin) and $10.5T in total client assets anchor valuation while M&A advisory (+30% YoY) and Equities trading (+41% YoY) drive upside. Q3 Key Takeaways & Valuation: - Revenue: $20.34B (+11.6% YoY) | GAAP EPS: $3.03 (+8.2% YoY) | ROTCE: 22.6% - Wealth Management NNA hit $232B ($80B fee-based flows) with rising NII, refuting sweep-account margin compression fears. - Weighted Fair Value: $219.00 (50% SOTP: $224.50, 35% RIM: $218.25, 15% DDM: $203.80). Key Risk & Catalyst: Soft Investment Management (-12% YoY) and equity underwriting (-19.5% YoY) caused a minor pullback, offering an entry backed by a 14.9% CET1 ratio and $1.5B Q3 buybacks. Not investment advice.

$MS Morgan Stanley reported an 11.6% year-over-year increase in Q3 revenue to $20.338 billion, beating Fiscal AI’s estimate of $20.1096 billion.

$MS Am I reading Earning Beat and stock is down 5%. Someone with a lot of financial knowledge, please enlighten

$MS Morgan Stanley printed 3.03 dollars in Q3, ahead of the 2.93 dollars FactSet had, on 20.34 billion dollars of revenue, up about 12 percent from a year ago. Equities did the heavy lifting again, 5.79 billion dollars, up 41 percent, while fixed income fell 7 percent to 2.01 billion dollars. Wealth came in at 9.07 billion dollars, up 10 percent, and investment banking added 2.16 billion dollars, up just 2 percent. Net income was 4.97 billion dollars.

$MS | MORGAN STANLEY Q3 2026 EARNINGS HIGHLIGHTS ◆ EPS: $3.03 vs. $2.93 est. ✅ ◆ Revenue: $20.34B vs. $19.93B est. ✅ ◆ Net Interest Income: $3.25B (+30.5% YoY) ◆ Net Income: $4.91B (+6.5% YoY) ◆ Provision for Credit Losses: $148M ◆ Non-Interest Expense: $13.71B (+12.4% YoY) Segment Performance: ◆ Institutional Securities: $10.03B (+17.7% YoY) ◆ Wealth Management: $9.07B (+10.1% YoY) ◆ Investment Management: $1.46B (-11.6% YoY) Key Metrics: ◆ Equity net revenues rose 41% YoY to $5.80B, driven by client engagement and strength in Asia. ◆ Share repurchases totaled $1.54B in Q3 2026 at an average price of $212.74; board declared $1.15 quarterly dividend per share. ◆ Standardized CET1 capital ratio was 14.9% at quarter-end, down from 15.1% a year ago. Forward Guidance: ◆ No guidance provided

$MS easy dip to buy. Nothing bad here. NNA growth and client asset growth QoQ even strong.

$MS | Equity Research Update Rating: BUY 12-Month Price Target: $219.00 (+15.3% upside vs. $190.02) Horizon: 12 Months Core Thesis: Morgan Stanley’s premier Wealth Management franchise (>53% fee-based revenue) dampens trading volatility while providing operating leverage into an accelerating global M&A and IPO underwriting recovery. Valuation Framework: • SOTP Model: $224.50 (18.5x WM / 13.5x IS P/E) • Residual Income Model: $218.25 (19.0% ROTCE vs. 9.85% Ke) • Capital Return DDM Floor: $203.80 Weighted Fair Value: $219.00 (3.7x forward P/TBV) Catalysts & Balance Sheet: • Q3 2026 earnings tomorrow pre-market (Consensus: $2.94 EPS / $20.19B revenue). • Capital return underpinned by 15.2% CET1 ratio, $4.60/yr dividend, and $20B buyback authorization. Primary Risk (Pre-Mortem Stress Test): Deposit beta headwinds and sweep-account yield adjustments pressuring Wealth Management net interest income. Not investment advice.